| 000 | 01489 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511165330.0 | ||
| 264 | 0 | _c19760126 | |
| 008 | 197601s 0 0 ger d | ||
| 022 | _a0025-8458 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFleckenstein, A | |
| 245 | 0 | 0 |
_a[Fundamental cardiac and vascular effects of Ca++-antagonistic coronary drugs]. _h[electronic resource] |
| 260 |
_bMedizinische Klinik _cOct 1975 |
||
| 300 |
_a1665-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAction Potentials |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 |
_aCalcium _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCats |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
| 650 | 0 | 4 |
_aDiltiazem _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGallopamil _xpharmacology |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNifedipine _xpharmacology |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
| 650 | 0 | 4 |
_aPrenylamine _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 773 | 0 |
_tMedizinische Klinik _gvol. 70 _gno. 42 _gp. 1665-74 |
|
| 999 |
_c1110112 _d1110112 |
||